LI
AUPH icon

LRI Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

LRI Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69K Hold
512
– – ﹤0.01% 996
2026
Q1 		$7.59K Hold
512
– – ﹤0.01% 963
2025
Q4 		$8.17K Hold
512
– – ﹤0.01% 924
2025
Q3 		$5.66K Buy
+512
New +$5.59K ﹤0.01% 1020

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LRI Investments's AUPH Position: Q2 2026 in Review

LRI Investments held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 512 shares worth $8.69K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

LRI Investments first reported a position in AUPH in Q3 2025 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • LRI Investments held 512 shares of Aurinia Pharmaceuticals worth $8.69K as of Q2 2026.
  • LRI Investments left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #996 holding.
  • LRI Investments first reported a position in Aurinia Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.